India's Metropolis Healthcare gains on upbeat Q3 earnings

Dr. Lal PathLabs

05/02/2025 07:30

** Shares of Metropolis Healthcare Ltd  METP.NS  rise 4.4% to
1,813.75 rupees
** Medical diagnostics firm reported a 15.5% rise in Q3 profit
on higher sales of costlier tests after market hours on Tuesday;
rev up 10%
    ** METP and larger rival Dr Lal PathLabs  DLPA.NS  rated
"Hold", while analysts rate smaller rival Vijaya Diagnostic
 VIJA.NS  "Buy" - LSEG
    ** Stock trims YTD losses to 12.8%, but trails DLPA's ~7%
loss and VIJA's 11% climb this year
     

(Reporting by Nandan Mandayam in Bengaluru)
((mailto:Nandan.Mandayam@thomsonreuters.com; Mobile: +91
9591011727;))